Due to the limited numbers of the commercially-available ER+/HER2+ breast cancer cell line, we used BT474 cells as a surrogate cell line model for PIK3CA-wt ER+/HER2+ breast cancer cell. This evidence concerns the gene PIK3CA and breast carcinoma.